Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Genet Dev. 1999 Feb;9(1):15-21.

    The oncogenic activation of beta-catenin.

    Source

    Onyx Pharmaceuticals, 3031 Research Drive, Richmond, California 94806, USA. ppolakis@onyx-pharm.com

    Abstract

    The activation of beta-catenin to an oncogenic state can result from the inactivation of the tumor suppressor adenomatous polyposis coli (APC), by direct mutation in the beta-catenin gene, or by the activation of wnt receptors. Once activated, beta-catenin most likely promotes tumor progression through its persistent interaction with one or more of its numerous downstream targets.

    PMID:
    10072352
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk